Delivery Order SPE2DR25D3501-SPE2DR26FL9QA
- Not listed
- The Defense Logistics Agency awarded a $267,465.18 delivery order to AmerisourceBergen Drug Corp for REVLIMID 10 mg capsules (100-count units) under a firm fixed-price contract. The order, issued on May 29, 2025, is scheduled for completion by June 20, 2025, and represents a competitive award with no set-aside designation. AmerisourceBergen's place of performance is located in Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $12,993.03 to AmerisourceBergen Drug Corp for the supply of Revlimid 5 mg capsules (quantity: 28 units). This is a competitively awarded, firm fixed-price delivery order with no set-aside designation, with an ultimate completion date of December 12, 2025. The pharmaceutical supply will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's headquarters and primary...
- The Defense Logistics Agency awarded a $27,425.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Revlimid 2.5 mg capsules (28-count units), with an ultimate completion date of September 29, 2025. This non-set-aside competitive award was issued on September 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Revlimid 25 mg capsules (100 count) with a ceiling value of $104,975.62. This firm fixed-price delivery order, which is expected to be completed by October 15, 2025, represents a non-set-aside, competitively awarded contract. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency awarded a $20,920.36 delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Revlimid 15 mg capsules (21-count units). This is a firm fixed price, non-set-aside contract with performance completion scheduled for December 10, 2025, and fulfillment occurring at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 8, 2025, for the supply of Revlimid 5 mg capsules (28-count) with a ceiling value of $12,329.15. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of October 30, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order valued at $25,840.56 to AmerisourceBergen Drug Corp for the supply of Revlimid 10 mg capsules (28-count units) under a firm fixed price contract. The award, issued on August 6, 2025, with an ultimate completion date of August 27, 2025, represents a non-set-aside, competitively awarded procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location and will fulfill...
- The Defense Logistics Agency awarded a delivery order valued at $58,220.97 to AmerisourceBergen Drug Corp for REVLIMID 10 MG capsules (28-count units) on September 17, 2025, with a completion date of October 8, 2025. The contract employs firm fixed pricing and was awarded competitively without set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Revlimid 25 mg capsules (100-count units) under a firm fixed-price contract valued at $52,487.80, with completion expected by September 26, 2025. This non-competitive delivery order represents a continuation of the company's critical role as a pharmaceutical supplier to the federal government. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Revlimid 10 mg capsules (28-count package) with a ceiling value of $102,180.00. This firm fixed-price delivery order, which is expected to be completed by September 17, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was...
- SPE2DR25D3501Indefinite Delivery Contract
- SPE2DR25D3501-SPE2DR26FL9QADelivery Order
The Defense Logistics Agency awarded a $10,254 firm fixed price delivery order to AmerisourceBergen Drug Corp for REVLIMID 25 mg capsules (21-count units) on December 1, 2025, with completion scheduled for December 22, 2025. This non-set-aside award was issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through December 2026. The product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, leveraging its comprehensive IDC to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's federal contract portfolio demonstrates consistent success in competitive procurement, with delivery orders spanning from small transactions to substantial orders exceeding $45,000. This delivery order represents a routine pharmaceutical procurement supporting the Defense Health Agency and other government healthcare customers through DLA's established medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.3k | 11/30/25 |